Perseus Proteomics Inc. [4882.T]
TOKYO, Jun 25 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) completed the exercise of warrant rights on June 25, 2026.
A total of 10,399 warrants were exercised on June 25, 2026, marking the completion of all outstanding warrants. Prior to this exercise, 145 warrants had been exercised since the last disclosure, bringing the cumulative number of exercised warrants to 10,399 out of a total issuance of 14,299 warrants. In the month of June, up to June 25, 2026, a total of 10,399 warrants were exercised, representing 72.72% of the total issuance. The breakdown includes exercises on June 22, June 24, and finally on June 25, 2026.
As of the end of May, there were 14,299 unexercised warrants, which decreased to 0 by the end of June. The company adhered to the exercise limitations set forth by the Tokyo Stock Exchange's Securities Listing Regulations Article 434 and the Japan Securities Dealers Association’s rules on third-party allotment increases. The exercise ratio was calculated at 9.69%. Details of the warrant issuance can be found in the previous announcement dated December 17, 2025.
🟡 Confidence: Standard AI-translated content.